Nicholas Lydon - Director at Blueprint Medicines Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
BPMC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Nicholas Lydon since 06 Jan 2025

Holdings reported by Nicholas Lydon for Blueprint Medicines Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 58,026 $6,100,273 $105.13 12 Jun 2024 Direct
Stock Option (Right to Buy) 4,570 $68,596 $15.01 12 Jun 2024 Direct Common Stock

Transactions reported by Nicholas Lydon for Blueprint Medicines Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.